Indonesia approves Merck’s COVID-19 pill for emergency use

15-Jan-2022 Intellasia | Reuters | 5:02 AM Print This Post

Indonesia has approved Merck & Co Inc’s (MRK.N) COVID-19 antiviral pill molnupiravir for emergency use, the country’s food and drug agency said in a statement.

A batch of 400,000 pills had arrived in Indonesia, health minister Budi Gunadi Sadikin said this week. The pill was jointly developed by US-based Merck and Ridgeback Biotherapeutics.


Category: Indonesia

Print This Post

Leave a Reply

You must be logged in to post a comment.